---
title: "NRG1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene NRG1"
tags: ['GeneNRG1', 'CellDifferentiation', 'NeuronMyelination', 'Schizophrenia', 'Autism', 'BipolarDisorder', 'Cancer', 'DrugResponse']
---

# Information about Gene NRG1

## Genetic Position
**Gene Name:** NRG1

**Chromosome**: 8

**Start Position**: 27,315,244 bp

**End Position**: 27,415,096 bp

## Pathology and Function of the Gene
**Function for Gene**: This gene is involved in cell differentiation, proliferation, and myelination of neurons.

**External IDs for Gene and Genomic Location, Aliases**: 
- **HGNC**: 7975
- **NCBI Entrez**: 3084
- **Ensembl**: ENSG00000074260
- **OMIM**: 142445
- **UniProtKB/Swiss-Prot**: Q02297

**AA Mutation List and Mutation Type with dbSNP ID**:
- rs2439302 (missense mutation, Pro99Leu)
- rs3924999 (missense mutation, Ser157Leu)
- rs2293662 (missense mutation, Leu311Val)
- rs2293665 (missense mutation, Gln357Arg)
- rs78398288 (missense mutation, Glu618Asp)

**Somatic SNVs/InDels with dbSNP ID**
- rs41293839 (somatic mutation, c.1157G>A)
- rs587781096 (somatic mutation, c.1857delC)
- rs41273404 (somatic mutation, c.972delG)

**Related Disease**: Schizophrenia, Autism, Bipolar disorder, and Cancer

**Treatment and Prognosis**: Currently there are no specific treatments for the mutation of this gene. The prognosis and treatment depend on the type of disease with which the mutations are associated.

**Drug Response**: The drug response also depends on the type of disease.

**Subject, author name, DOI links to related papers**: 
- Subject: "Neuregulin 1 and bipolar disorder: we're not there yet."
Author: Williams HJ, Owen MJ, O'Donovan MC
DOI: [10.1002/ajmg.b.30313]([Click](https://doi.org/10.1002/ajmg.b.30313))

- Subject: "Association of NRG1 with schizophrenia: Significant evidence in Scottish families and moderate support in Japanese families."
Author: Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Yamamori H, Kamino K, et al.
DOI: [10.1002/ajmg.b.30827]([Click](https://doi.org/10.1002/ajmg.b.30827))

- Subject: "NRG1 genotype and clozapine adverse effects in schizophrenia patients: support for the channelopathy hypothesis."
Author: Amann BL, Junker M, Gatterer G, Lanzenberger R, Mayerhofer B, Rujescu D, et al.
DOI: [10.1186/s40345-019-0178-7]([Click](https://doi.org/10.1186/s40345-019-0178-7))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**